Skip to content

Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement

Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00548392
Enrollment
25
Registered
2007-10-24
Start date
2007-05-31
Completion date
2008-09-30
Last updated
2008-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast, cancer, ultrasound, high risk, marker clip

Brief summary

The purpose of this study is to determine how long collagen based marker clips remain visible by ultrasound after placement in suspicious breast lesions and if collagen based marker clips can be reliably identified in the operating room and serve as effective guidance for surgical removal of high risk or malignant breast lesions.

Detailed description

Many breast cancers and other breast lesions are discovered as a palpable abnormality by patients or their providers during a breast exam. Diagnostic imaging and biopsy of these lesions may reveal high-risk or malignant findings. These palpable lesions can be removed in the operating room by the surgeon using touch as guidance. However, there are many lesions discovered by screening examinations that surgeons cannot palpate. When this occurs, a radiologist will percutaneously place a wire or wires at the site of the breast lesion using sonographic or mammographic guidance. The surgeon then uses the wires as a guide for complete and successful resection of the lesion. New marker devices have been developed that are sonographically visible. They consist of the standard mammographically visible metallic clip surrounded by a sonographically visible collagen plug. It is hypothesized that radiologists and surgeons can effectively localize the clip with intra-operative ultrasound and then resect the lesion. If so, the pre-operative wire localization procedure could be eliminated. This could improve the patient experience while saving time and money by reducing the number of invasive procedures from 3 (biopsy, wire-localization and operation) to 2 (biopsy and operation).

Interventions

None listed

Sponsors

Ethicon Endo-Surgery
CollaboratorINDUSTRY
GE Healthcare
CollaboratorINDUSTRY
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with suspicious breast lesions that have undergone biopsy and marker clip placement within 28 days (4 weeks) of pre-operative consultation visit. * Patients or their legal representative must be able to provide written informed consent. * Patients must be over 18 years old.

Exclusion criteria

* Under the age of 18 years * Unable to give written informed consent * Patients will be excluded if the clip was placed more than 4 weeks prior to their pre-operative appointment or wire-localization.

Design outcomes

Primary

MeasureTime frame
Visibility of marker clip after placement in suspicious breast lesions.Within 4 weeks of placement

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026